eosinophils 3%.
Platelets were normal. Urinalysis: specific gravity 1017; pH 7.0; 5 to 7 WBC per high power field. A few hyaline casts were noted. Serum electrolytes: BUN 56 mg/100 ml; uric acid 9.8 mg/100 ml; creatinine 2 mg/100 ml; glucose 80 mg/100 ml; sodium 128 meq/l; potassium 6 meq/l; chlorides 95 meq/l; and CO 2 23 meq/]. Coccidioidin and intermediate tuberculin skin tests were positive. A morning plasma cortisol level was 2 jlg/100 m\. After the administration of dexamethasone 0.5 mg twice daily the plasma cortisol level was 2 mg/100 m\. The patient was then given ACTH 40 units in 1000 ml of 5% dextrose and water intravenously over an eight-hour period for two days. The total urinary 17 ketosteroids were 6 mg/24 .hours (normal for women 6-15) and the total ketogenic steroids were 3 mg/24 hours (normal for women 3-15). The patient was given cortisone 37.5 mg daily. After 5 days her plasma cortisol level rose to 9 mg/100 m\. Three urine concentrates and cultures were negative for acid-fast baciIli.
The diagnosis of Addison's disease was made and the patient was given cortisone 25 mg in the morning and 12.5 mg in the middle of the afternoon. Fludrocortisone (Florinef) 0.2 mg, table salt 10 grains, isoniazid 300 mg and thyroid extract 2 grams taken daily were other medications given.
During the following year (1977) the patient developed frequent right frontal headaches, easy fatiguability especially in the afternoon and epigastric pain. An upper GI series in June 1978 was norma\. The dose of cortisone was increased to 50 mg daily and the symptoms were relieved. On 22 January 1979 the patient developed redness and sweIling of.the right eye. A few weeks later she noted a crop of red nodules on the medial surface of the left forearm. In the next two weeks more nodules appeared on her back and right forearm. These nodules were painless and non-pruritic. A chest X-ray was norma\. On 27 April the patient developed sudden painful sweIling of both parotid glands .and more subcutaneous nodules on the forearm. Her elbows had ached and frontal headaches continued. A punch biopsy of one of the nodules was consistent with erythema nodosum. On 3 May 1979 the patient noted more nodules on the face, extremities and the trunk. She had lost 121b (5.4 kg) in weight. Her sedimentation rate was 33 mm/h and ANA titre was I: 160. Serum calcium and serum proteins were norma\. Prednisolone 30 mg daily was added to her regimen. After one week she felt much better and the parotid swelling became smaller. After one month the parotid glands returned to almost normal size and the subcutaneous nodules subsided. However, the patient then reduced prednisolone on her own which resulted in recurrence of subcutaneous nodules, and swelling and tenderness of both parotid glands. She was readmitted to hospital on 24 September 1979 for muscle aches, dry mouth, and dry eyes. She appeared deeply tanned. The thyroid was multinodular. Both parotids were enlarged and tender, left slightly more than the right. The blood pressure was 90/70. Skin, in addition to the deep tanning, revealed patchy vitiligo on the neck and back. Laboratory investigations: WBC count 5700 mm': polymorphs 64%; lymphocytes 22%; monocytes 9%; esinophils 5%. Platelets were adequate. A rheumatoid arthritis factor was O. Antiadrenal, anti skeletal muscle, antimitochondrial, anti thyroglobulin, and anti microsomal antibodies were all negative. An antismooth muscle antibody was positive in I: 10. Sjogren's antibodies (SS-A and SS-B) were negative. Schirmer test was abnormal. 'On 26 September 1979 a buccal biopsy revealed noncaseating granulomas involving the minor salivary glands. Serum angiotensin-converting enzyme was 37 units (normal for women 10--30). Serum calcium was normal.
The patient continues to receive cortisone 75 mg, Florinef 0.2 mg, salt 10 grams, isoniazid 300 mg, pyridoxine 50 mg, and thyroid extract 2 grains daily; prednisolone was tapered off by January 1982. At this time she had a persistent nonproductive hacking cough and dryness of the eyes and the mouth. The parotid glands were no longer tender or enlarged, and subcutaneous nodules had subsided.
Discussion
This patient developed thyroid disease in 1974. It is not clear from the history if she had Graves' disease which resolved spontaneously or Hashimoto's thyroiditis. Two years later she was diagnosed as having Addison's disease. This was followed by the appearance of clinical features of Sjogren's syndrome, vitiligo and sarcoidosis. The latter diagnosis is based on the histological evidence of non-caseating granulomata in the buccal biopsy specimen, elevated serum angiotensin-converting enzyme level and erythema nodosum. Thus this patient has a rare clinical autoimmune syndrome which combines the features of thyroiditis, Addison's disease, Sjogren's syndrome and sarcoidosis and could result from multisystem granulomatous spread. The other possibility is that the syndrome could result from an autoimmune disturbance resulting from loss of T-cell control. Volpe (1977) believes that most, if not all, of the organ-specific autoimmune disorders such as Hashimoto's thyroiditis, Graves' disease, idiopathic Addison's disease, Sjogren's syndrome, and myasthenia gravis are the result of a specific defect in suppressor T-cells. He views this defect as permitting the liberation of a 'forbidden' clone of organ-specific self-reactive T-cells and the activation of B-cells, resulting in both cellmediated and humoral hypersensitivity. The freeing of more than one 'forbidden clone' would result in an additional disorder(s) and would explain the frequent occurrence of these disorders. The similar immunoregulatory defect postulated for sarcoidosis could explain its apparent association with many autoimmune disorders (Wiesenhutter & Sharma 1979) . Conversely, sarcoid granulomas have been seen in the thyroid and the parathyroid glands. It is more likely that the endocrine changes were caused primarily by granulomas rather than autoimmunity.
The association of thyroiditis and sarcoidosis has been largely ignored. Maycock et al. (1963) , in their study of 145 sarcoidosis patients, mentioned in passing that 2 (1.4%) had clinical evidence of thyroiditis. Karlish & MacGregor (1970) described 4 (1.3%) patients with clinical features of 'thyroiditis amongst their 300 sarcoidosis patients. Hancock & Millard (1976) reported 5 cases with thyrotoxicosis and sarcoidosis amongst 2100 patients attending a thyroid clinic. They reviewed the literature and described the 20 previously reported cases, concluding that such an association could result from an autoimmune disturbance resulting from loss of T-cell control.
The association of thyroiditis and Addison's disease is called Schmidt's syndrome (Alarcon-Segovia et al. 1974 ). Addison's disease also occurs in association with thyrotoxicosis, pernicious anaemia, idiopathic hypoparathyroidism and diabetes mellitus. Histologically the adrenal lesion resembles the thyroid atrophy of myxoedema and the atrophic gastritis of pernicious anaemia (British Medical Journal 1969) . The occurrence of idiopathic Addison's disease and sarcoidosis in the same patient is rare and has been reported only eight times, Sjogren's syndrome, a chronic inflammatory disorder characterized by dryness of the eyes, mouth and other mucous membranes, is a disease of menopausal women. More than 50% of the patients have an associated connective tissue disease. James (1959) found 4 cases of Sjogren's syndrome in one series of 200 sarcoidosis patients. Turiaf & Battesti (1978) contend that oculosalivary involvement identical with that of Sjogren's syndrome can occur in association with true sarcoidosis lasting over a number of years. Alarcon-Segovia et al. (1974) reported that in disseminated lupus erythematosus, scleroderma, active chronic hepatitis, primary biliary cirrhosis and rheumatoid arthritis, at least two of the criteria (clinical, histological, sialographic, scintigraphic) actually necessary for a diagnosis of Sjogren's syndrome are always constant. Thus sarcoidosis, as well as other autoimmune diseases, may have a common origin with Sjogren's syndrome.
The abnormalities and features of the immune system in sarcoidosis are consistent with the assumption that there is a defect in the suppressor regulatory system (James & Williams 1982) . The apparent similarity of this immunological profile to the abnormalities found in animal models of autoimmunity and human systemic lupus erythematosus (SLE) raises, once more, the possibility that some yet undiscovered relationship exists between sarcoidosis and autoimmune disorders, However, the inclusion of sarcoidosis in the group of disorders of autoimmunity has not been generally accepted. It would be interesting to examine sarcoidosis by a battery of newly-developed tests used for SLE and other autoimmune disorders. This approach might be helpful in determining whether the two conditions are coincidental or causally related. It is currently accepted that major histocompatibility complex genes confer susceptibility to the development of autoimmmune disorders. Sjogren's syndrome and autoimmune thyroid disease appear to be associated with HLA-88 and HLA-DRW3 histocompatibility antigens (Moutsopoulos et al. 1979 , Moens & Farid 1978 . Although there is no strong evidence to support an association between HLA and the development of sarcoidosis, it has been pointed out that sarcoidosis patients in London with HLA-B8 are likely to have arthritis and/or erythema nodosum (Neville et al. 1980 , Turton et al. 1980 , Eisenberg et al. 1978 . However, not all patients with these manifestations have 88 antigen and not all with 88 antigen will develop these lesions. Clearly other factors are important. More genetic markers are needed to increase understanding of the mechanisms influencing the association of sarcoidosis and other autoimmune disorders.
